There are no known causes and usually multiple factors leading to the common condition that makes stools hard and difficult to pass, according to the FDA. Linzess was approved in 2012 for adult patients with constipation, and more than 10 years later, it’s approved for patients between 6 and 17 years old.
In a phase 3 trial, pediatric patients who took Linzess had more spontaneous bowel movements than those who took the placebo after 12 weeks. In the study, 4 percent of Linzess patients experienced diarrhea, which was the most common side effect.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
